Common Stock, Shares, Outstanding of Kairos Pharma, LTD. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Kairos Pharma, LTD. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Kairos Pharma, LTD. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 20,821,353, a 62% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Kairos Pharma, LTD. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 20,821,353 +7,974,568 +62% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 17,743,765 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 15,825,118 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 13,736,597 +3,173,957 +30% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 12,846,785 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q4 2023 10,562,640 31 Dec 2023 10-K 15 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.